Activating variants in <scp><i>PDGFRB</i></scp> result in a spectrum of disorders responsive to imatinib monotherapyTara Wenger, William B. Dobyns, Jirat Chenbhanich et al.|American Journal of Medical Genetics Part A|2020Cited by 34